Neurologic function and neuromuscular blocking agents in critical care

Area of Science:

• Critical care medicine
• Neuroscience
• Pharmacology

Background:

• Neuromuscular blocking agents (NMBAs) are critical for managing life-threatening conditions in intensive care units (ICUs).
• Optimizing cerebral preservation is a primary goal of life support, including mechanical ventilation and hemodynamic stability.
• Current critical care practices extensively monitor most organs but neglect neurological assessment during NMBA therapy.

Purpose of the Study:

• To address the neurological complications associated with NMBA use in critical care.
• To identify patients at higher risk for neurological events during NMBA therapy.
• To explore the rationale and methods for monitoring cerebral changes during paralytic therapy.

Main Methods:

• Review of existing literature on NMBA use and neurological monitoring in critical care.
• Identification of risk factors for neurological compromise in patients receiving NMBAs.
• Discussion of potential assessment and intervention strategies for cerebral changes.

Main Results:

• Neurological stability is often unevaluated in patients receiving NMBAs.
• Specific patient populations may be at increased risk for adverse neurological outcomes.
• Methods for monitoring and intervening in cerebral changes during NMBA therapy require further development and implementation.

Conclusions:

• There is a critical need to integrate neurological monitoring into the care of patients receiving NMBAs in ICUs.
• Proactive assessment and intervention are necessary to ensure cerebral preservation during paralytic therapy.
• Further research is warranted to establish standardized protocols for neurological assessment during NMBA administration.